Sign in / Join Now
ETFs & Funds
Roy Manning III
; possible value play. Recent deal and pipeline all for $25 million market cap. Company finds and patents second uses for existing drugs
Add a reply...
Latest StockTalks »
people get SYN breaking news and analysis by email alert.
Get email alerts on SYN »
Synthetic Biologics, Inc.
Get latest price
From other sites
Synthetic Biologics To Report Third Quarter 2016 Operational Highlights And Financial Results On November 1, 2016
at TheStreet (Tue, 6:58AM)
Synthetic Biologics Wins Research Contract (SYN)
at Investopedia (Oct 8, 2016)
Synthetic Biologics Awarded Research Contract From Centers For Disease Control And Prevention (CDC) For Microbiome Assessment And Intervention To Address Antibiotic Resistance
at TheStreet (Oct 6, 2016)
Synthetic Biologics: 3 Reasons Why SYN Is a Top Choice for Momentum Investors
at Zacks.com (Sep 29, 2016)
Synthetic Biologics Announces Completion Of Enrollment For Phase 2b Proof-of-Concept Clinical Trial For SYN-004 (ribaxamase) For The Prevention Of Clostridium Difficile Infection, Antibiotic-Associated Diarrhea And The Emergence Of Antibiotic-Resistant Organisms
at TheStreet (Sep 20, 2016)